As of 2025-06-25, the EV/EBITDA ratio of IGEA Pharma NV (IGPH.SW) is -0.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IGPH.SW's latest enterprise value is 1.04 mil CHF. IGPH.SW's TTM EBITDA according to its financial statements is -1.28 mil CHF. Dividing these 2 quantities gives us the above IGPH.SW EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |